|

Irinotecan Liposome Clinical Trials

8 actively recruiting trials

Also known as: Irinotecan liposome injection

Pipeline

Phase 1: 1Phase 2: 5

Top Sponsors

Fudan University2
West China Hospital1
Sun Yat-sen University1
Shanghai Zhongshan Hospital1
Peking University1

Indications

Cancer8
Recurrent or Metastatic Nasopharyngeal Carcinoma2
Metastatic Colorectal Cancer2
Pancreatic Cancer Metastatic to Liver1
Small Cell Lung Cancer Recurrent1

Other8 trials

Adebelimab Combined With Irinotecan Liposomal Injection, Oxaliplatin, Fluorouracil and Calcium Folinate Are Used in the First-line Treatment of Pancreatic Cancer Liver Metastasis Efficacy and Safety

Phase 2

Adebrelimab in Combination With NALIRIFOX in Locally Advanced Pancreatic Cancer

Phase 2

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Phase 2

Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer

Phase 1

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

N/A

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Phase 2

Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer

Phase 2

Real-world Study to Evaluate the Efficacy and Safety of Liposome Irinotecan

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.